Andean Precious Metals (CVE:APM) Shares Down 8% – Here’s Why

Andean Precious Metals Corp. (CVE:APM)’s stock price fell 8% during mid-day trading on Tuesday . The company traded as low as C$1.12 and last traded at C$1.15. 461,849 shares changed hands during mid-day trading, an increase of 139% from the average session volume of 193,266 shares. The stock had previously closed at C$1.25.

Wall Street Analysts Forecast Growth

Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a report on Thursday, October 31st.

Andean Precious Metals Stock Down 11.2 %

The company’s fifty day moving average is C$1.46 and its two-hundred day moving average is C$1.25. The stock has a market cap of C$165.79 million, a price-to-earnings ratio of 2.92 and a beta of 1.22.

Insider Activity

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. purchased 84,400 shares of the stock in a transaction that occurred on Tuesday, October 8th. The stock was purchased at an average cost of C$1.51 per share, with a total value of C$127,359.60. In the last three months, insiders have bought 306,200 shares of company stock worth $432,953. 69.37% of the stock is currently owned by corporate insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.